What is an FDA Calendar? Biotech investing is risk-fraught, as stocks are at the mercy of several catalysts – most of which are make-or-break events, aka binary events. A prudent investment ...

On October 29, 1959, the pharmaceutical company G.D. Searle filed an application with the U.S. Food and Drug Administration (FDA) to license their drug Enovid for use as an oral contraceptive.

The emblem of a red cross on a white background is a sign of protection under the Geneva Conventions. It is not a religious symbol. The red cross, red crescent and red crystal are symbols of ...

Kennedy Jr., who is slated to hold a potentially big role in a new Trump administration, said Wednesday there are “entire departments” within the Food and Drug Administration (FDA) that ...

The Food and Drug Administration is issuing exemptions from the Drug Supply Chain Security Act’s current final implementation deadline for some drug manufacturers and distributors, according to ...

FDA to review if there's a shortage of tirzepatide Outsourcing Facilities Association lawsuit led to FDA reconsideration Shortages of Lilly and Novo Nordisk drugs drive demand for compounded ...

The Food and Drug Administration approved a drug produced by AbbVie for the treatment of late stage Parkinsons disease the company announced Thursday. The regulator approved Vyalev, also known as ...

Oct 17 - The U.S. Food and Drug Administration has approved Avadel Pharmaceuticals' (AVDL.O), opens new tab sleep disorder drug for children aged 7 years and older, broadening its use and heating ...

The USDA has simplified nutrition guidelines with its "MyPlate" campaign. MyPlate replaces the older Food Pyramid. Considering that salt is an ingredient in just about every type of processed food ...

In order to receive the GHNA emblem, products must meet nutrition criteria informed by the latest evidence-based nutrition authoritative guidance from the 2015-2020 Dietary Guidelines for Americans, ...

The FDA periodically inspects facilities that manufacture dietary ... Dietary supplements that have gone through third-party testing will typically include the certification emblem on their packaging.

UGN-102 could become the first FDA-approved medicine for the treatment of low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC). The FDA has assigned a Prescription Drug ...